Filing Flows

Filing Flows › Lemaitre Vascular (LMAT) › Recalls, complaints & regulation

Lemaitre Vascular (LMAT): recalls and clinical trials

Lemaitre Vascular (LMAT) beyond its filings: 2 recalls in the last 12 months (11 in five years, 0 Class I); 5 active clinical trials.

Latest recalls

Lemaitre Vascular's latest quarter

Lemaitre Vascular, Q3 2026: revenue $68.0M (+11% year over year), operating margin 26.0%, net earnings $15.0M, operating cash flow $22.0M. The chart follows the revenue to costs, profit and cash.

Questions

Has Lemaitre Vascular had any recalls?

11 recalls on file over five years from the FDA, CPSC and NHTSA; 2 in the last 12 months.

How many clinical trials does Lemaitre Vascular have?

5 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.